Virtus ETF Advisers’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Buy
2,888
+138
+5% +$15K 0.17% 160
2026
Q1
$254K Hold
2,750
0.12% 195
2025
Q4
$281K Buy
+2,750
New +$246K 0.13% 179

Other funds holding GH

Virtus ETF Advisers's GH Position: Q2 2026 in Review

Virtus ETF Advisers increased its Guardant Health (GH) stake by 5% in Q2 2026, buying an estimated $15K and bringing the position to 2,888 shares worth $433K. The position accounts for 0.17% of the portfolio, ranked #160.

Virtus ETF Advisers first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Virtus ETF Advisers held 2,888 shares of Guardant Health worth $433K as of Q2 2026.
  • Virtus ETF Advisers bought 138 Guardant Health shares in Q2 2026, an estimated $15K.
  • Guardant Health made up 0.17% of Virtus ETF Advisers's portfolio in Q2 2026, its #160 holding.
  • Virtus ETF Advisers first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.